Brenntag Specialties Pharma offering phosphate-based excipients by Budenheim
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Loteprednol Etabonate Ophthalmic Suspension, 0.5% is indicated for the treatment of steroidresponsive inflammatory conditions of the palpebral and bulbar conjunctiva
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Godavari Biorefineries receives patent from CNIPA
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Subscribe To Our Newsletter & Stay Updated